Vendor review
Henan Sahe Peptide reviews
Henan Sahe Peptide reviews from 95 independent lab tests (Retatrutide, Tirzepatide and GHK-Cu): grade A, purity and fill accuracy. Is Henan Sahe Peptide legit? See what its vials showed.
What the lab tests show
95 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Oct 9, 2026 | Retatrutide | 30 mg | Fail | View | |
| Oct 8, 2026 | Cagrilintide | 99.9 % | 5.55 mg of 5 mg (11 %) | Pass | View |
| Oct 6, 2026 | Retatrutide | 99.9 % | 35.9 mg of 30 mg (20 %) | Pass | View |
| Oct 6, 2026 | Cagrilintide | 10 mg | Fail | View | |
| Oct 6, 2026 | GHK-Cu | 99.9 % | 66.6 mg of 50 mg (33 %) | Pass | View |
| Oct 6, 2026 | Tesamorelin | 99.9 % | 24.5 mg of 20 mg (23 %) | Pass | View |
| Oct 1, 2026 | GHK-Cu | 99.9 % | 99.99 mg of 100 mg (0 %) | Pass | View |
| Sep 30, 2026 | Retatrutide | 99.9 % | 19.99 mg of 20 mg (0 %) | Pass | View |
| Sep 25, 2026 | Tirzepatide | 99.9 % | 61 mg of 60 mg (2 %) | Pass | View |
| Sep 24, 2026 | Retatrutide | 99.9 % | 29.3 mg of 30 mg (-2 %) | Pass | View |
| Sep 24, 2026 | GHK-Cu | 99.9 % | 49.99 mg of 50 mg (0 %) | Pass | View |
| Sep 24, 2026 | Tirzepatide | 99.9 % | 59.99 mg of 60 mg (0 %) | Pass | View |
| Sep 23, 2026 | Retatrutide | 99.9 % | 20.4 mg of 20 mg (2 %) | Pass | View |
| Sep 23, 2026 | Retatrutide | 99.9 % | 9.03 mg of 10 mg (-10 %) | Pass | View |
| Sep 4, 2026 | CJC-IPA | 99.5 % | 14.8 mg of 20 mg (-26 %) | Pass | View |
| Aug 27, 2026 | Tirzepatide | 89.23 % | 12.81 mg of 40 mg (-68 %) | Pass | View |
| Aug 9, 2026 | Retatrutide | 20 mg | Fail | View | |
| Aug 4, 2026 | Retatrutide | 99.9 % | 20.8 mg of 20 mg (4 %) | Pass | View |
| Jul 28, 2026 | KLOW | 80 mg | Fail | View | |
| Jul 23, 2026 | GHK-Cu | 99.5 % | 94.5 mg of 100 mg (-6 %) | Pass | View |
| Jul 20, 2026 | Retatrutide | 99.9 % | 10.2 mg of 10 mg (2 %) | Pass | View |
| Jul 17, 2026 | Retatrutide | 10 mg | Fail | View | |
| Jul 14, 2026 | Tirzepatide | 30 mg | Fail | View | |
| Jul 13, 2026 | Tirzepatide | 99.9 % | 57.1 mg of 60 mg (-5 %) | Pass | View |
| Jul 13, 2026 | Retatrutide | 99.7 % | 19 mg of 20 mg (-5 %) | Pass | View |
| Jul 13, 2026 | KLOW | 99.4 % | 8.78 mg of 80 mg (-89 %) | Pass | View |
| Jul 10, 2026 | Tirzepatide | 99.8 % | 10.7 mg of 10 mg (7 %) | Pass | View |
| Jul 1, 2026 | Retatrutide | 99.9 % | 9.07 mg of 10 mg (-9 %) | Pass | View |
| Jul 1, 2026 | MOTS-c | 10 mg | Fail | View | |
| Jul 1, 2026 | CJC-IPA | 99.3 % | 11 mg of 10 mg (10 %) | Pass | View |
| Jun 26, 2026 | Retatrutide | 99.7 % | 10.4 mg of 10 mg (4 %) | Pass | View |
| Jun 26, 2026 | Retatrutide | 99.4 % | 5.7 mg of 5 mg (14 %) | Pass | View |
| Jun 26, 2026 | GHK-Cu | 99.6 % | 73.5 mg of 50 mg (47 %) | Pass | View |
| Jun 24, 2026 | Retatrutide | 99.9 % | 17.8 mg of 20 mg (-11 %) | Pass | View |
| Jun 24, 2026 | Retatrutide | 99.9 % | 16.7 mg of 20 mg (-17 %) | Pass | View |
| Jun 22, 2026 | Retatrutide | 30 mg | Fail | View | |
| Jun 22, 2026 | GHK-Cu | 99.9 % | 13.1 mg of 100 mg (-87 %) | Pass | View |
| Jun 22, 2026 | MOTS-c | 40 mg | Fail | View | |
| Jun 22, 2026 | CJC-IPA | 79.8 % | 10.98 mg of 10 mg (10 %) | Pass | View |
| Jun 22, 2026 | KLOW | 99.4 % | 76.29 mg of 80 mg (-5 %) | Pass | View |
| Jun 17, 2026 | Retatrutide | 99.7 % | 4.9 mg of 5 mg (-2 %) | Pass | View |
| Jun 16, 2026 | MOTS-c | 20 mg | Fail | View | |
| Jun 12, 2026 | Retatrutide | 99.5 % | 10.8 mg of 10 mg (8 %) | Pass | View |
| Jun 12, 2026 | Retatrutide | 99.8 % | 33.7 mg of 30 mg (12 %) | Pass | View |
| Jun 12, 2026 | Tirzepatide | 99.7 % | 36.3 mg of 40 mg (-9 %) | Pass | View |
| Jun 4, 2026 | Retatrutide | 92.4 % | 9.67 mg of 10 mg (-3 %) | Pass | View |
| May 20, 2026 | Retatrutide | 99.9 % | 5.56 mg of 5 mg (11 %) | Pass | View |
| May 20, 2026 | Tirzepatide | 99.9 % | 40.9 mg of 40 mg (2 %) | Pass | View |
| May 20, 2026 | Tirzepatide | 99.9 % | 20.4 mg of 20 mg (2 %) | Pass | View |
| May 20, 2026 | Tirzepatide | 99.9 % | 10.3 mg of 10 mg (3 %) | Pass | View |
| May 20, 2026 | Retatrutide | 99.9 % | 30.5 mg of 30 mg (2 %) | Pass | View |
| May 20, 2026 | Cagrilintide | 99.3 % | 5.1 mg of 5 mg (2 %) | Pass | View |
| May 6, 2026 | Retatrutide | 99.9 % | 15.9 mg of 15 mg (6 %) | Pass | View |
| May 6, 2026 | Semaglutide | 20 mg | Fail | View | |
| Apr 30, 2026 | Retatrutide | 99.8 % | 31.4 mg of 30 mg (5 %) | Pass | View |
| Apr 27, 2026 | Retatrutide | 30 mg | View | ||
| Apr 23, 2026 | TB-500 | 98.1 % | 10.4 mg of 10 mg (4 %) | Pass | View |
| Apr 23, 2026 | Retatrutide | 99.9 % | 19.6 mg of 20 mg (-2 %) | Pass | View |
| Apr 23, 2026 | MOTS-c | 99 % | 10.2 mg of 10 mg (2 %) | Pass | View |
| Apr 23, 2026 | Tesamorelin | 99.1 % | 10.4 mg of 10 mg (4 %) | Pass | View |
What Henan Sahe Peptide sells
No current listings on record.
About Henan Sahe Peptide
Finnrick has tested 95 samples from Henan Sahe Peptide across 11 products.